洪宗民

職稱主治醫師

專長鼻咽癌、頭頸部腫瘤、食道癌、乳癌
學歷1997~2004 國立台灣大學醫學院醫學系
經歷2003~2004 台灣大學醫學院附設醫院 實習醫師
2006~2010 林口長庚紀念醫院放射腫瘤科 住院醫師
2010~    林口長庚紀念醫院放射腫瘤科 主治醫師


參與學會台灣放射腫瘤學會
美國放射腫瘤學會
發表論文

Publications

  • WK Yap, YC Chang, CH Hsieh, YK Chao, CC Chen, MC Shih, TM Hung*. Favorable versus unfavorable prognostic groups by post-chemoradiation FDG-PET imaging in node-positive esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy. European Journal of Nuclear Medicine and Molecular Imaging 2018; 45(5): 689-698. (SCI; IF=7.081; Radiology, Nuclear Medicine & Medical Imaging: 5/133 = 3.76%)
  • Hung TM, Fan KH, Kang CJ, Huang SF, Lin CY, Ho AT, Wang HM, Hsieh JC, Cheng AJ, Ng SH, Chang JT*. Lymph node to primary tumor standardized uptake value ratio on PET predicts distant metastasis in nasopharyngeal carcinoma. Oral Oncology 2020; 110: 104756. (SCI; IF=3.979; Dentistry, Oral Surgery & Medicine: 5/91 = 5.5%)
  • PJ Chen, WK Yap, YC Chang, CK Tseng, YK Chao, JC Hsieh, PC Pai, CH Lee, CK Yang, AT Ho, TM Hung*. Prognostic value of lymph node to primary tumor standardized uptake value ratio in unresectable esophageal cancer. BMC Cancer 2020; 20: 545. (SCI; IF=3.150; Oncology: 129/244 = 52.9%)
  • Hung TM, Lin CR, Chi YC, Lin CY, Chen EY, Kang CJ, Huang SF, Juang YY, Huang CY*, Chang JT*. Body image in head and neck cancer patients treated with radiotherapy: the impact of surgical procedures. Health and Quality of Life Outcomes 2017; 15: 165. (SCI; IF=2.344; Health Care Sciences & Services: 43/102 = 42.2%)
  • WK Yap, YC Chang, CK Tseng, CH Hsieh, YK Chao, PJ Su, MM Hou, CK Yang, PC Pai, CR Lin, CE Hsieh, YY Wu, TM Hung*. Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer. Diseases of the Esophagus 2017; 30, 1-10. (SCI; IF=2.386; Gastroenterology & Hepatology: 66/88 = 75%)
  • Hung TM, Fan KH, Chen EY, Lin CY, Kang CJ, Huang SF, Liao CT, Ng SH, Wang HM, Chang JT*. An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result. Medicine 2017; 96(6): e6036. (SCI; IF=1.552; Medicine, General & Internal: 89/165 = 53.9%)
  • Hung TM, Chen CC, Lin CY, Ng SH, Kang CJ, Huang SF, Liao CT, Fan KH, Wang HM*, Chang JT*. Prognostic value of prepontine cistern invasion in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy. Oral Oncology 2014; 50: 228-233. (SCI; IF=3.979; Dentistry, Oral Surgery & Medicine: 5/91 = 5.5%)
  • Hung TM, Wang HM, Kang CJ, Huang SF, Liao CT, Chan SC, Ng SH, Chen IH, Lin CY, Fan KH, Chang JT*. Pretreatment 18F-FDG PET standardized uptake value of primary tumor and neck lymph nodes as a predictor of distant metastasis for patients with nasopharyngeal carcinoma. Oral Oncology 2013; 49: 169-174. (SCI; IF=3.979; Dentistry, Oral Surgery & Medicine: 5/91 = 5.5%)
  • Lin CH, Hung TM, Chang YC, Hsieh,CH, Shih MC, Huang SM, Yang CK, Chang CF, Chan SC, Yap WK*. Prognostic Value of Lymph Node-To-Primary Tumor Standardized Uptake Value Ratio in Esophageal Squamous Cell Carcinoma Treated with Definitive Chemoradiotherapy. Cancers 2020; 12(3):607. (SCI; IF=6.126; Oncology: 37/244 = 15.2%)
  • Hung TM, Hong JH, Leung WM, Lin CY, Tsan DL, Tsang NM*. Radiation Therapy for Advanced Hepatocellular Carcinoma With Hepatic Hilum Involvement and High Bilirubin Level: Better Survival in Decreased Bilirubin After Radiotherapy. Therapeut Radiol Oncol 2009; 16(3): 179-194
  • YY Chiang, YC Chou, KP Chang, CT Liao, YY Wu, WK Yap, PC Pai, JT Chang, CY Lin, KH Fan, BS Huang, TM Hung, NM Tsang*. Missed radiation therapy sessions in first three weeks predict distant metastasis and less favorable outcomes in surgically treated patients with oral cavity squamous cell carcinoma. Radiation Oncology 2020; 15(1):194. (SCI; IF=2.817; Radiology, Nuclear Medicine & Medical Imaging: 47/133 = 35.3%)
  • X Zhang, BM Eyck, Y Yang, J Liu, YK Chao, MM Hou, TM Hung, Q Pang, ZT Yu, H Jiang, S Law, I Wong, KO Lam, BJ Wilk, AV Gaast, MC Spaander, R Valkema, SM Lagarde, BP Wijnhoven, JJ Lanschot, Z Li*. Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study. BMC Cancer 2020; 20: 194. (SCI; IF=3.150; Oncology: 129/244 = 52.9%)
  • Chen SC*, Huang BS, Hung TM, Lin CY, Chang YL, Chung CY. Factors Associated With Resilience Among Primary Caregivers of Patients With Advanced Cancer Within the First 6 Months Post‐Treatment in Taiwan: A Cross‐Sectional Study. Journal of Nursing Scholarship 2020; 52(5): 488-496. (SCI; IF=2.655; Nursing: 4/123 = 3.3%)
  • Lin CR, Fan KH, Lin CY, Hung TM, Huang BS, Chen EY, Kang CJ, Huang SF, Chang JT*, Chang CH*. Development and evaluation of a computerized clinical outcome assessment tool for head and neck cancer patients. Medicine 2020; 99(34): e20304. (SCI; IF=1.552; Medicine, General & Internal: 89/165 = 53.9%)
  • Chang YL, Huang BS, Hung TM, Lin CY, Chen SC*. Factors influencing body image in posttreatment oral cavity cancer patients. Psycho-Oncology 2019; 28(5): 1127-1133. (SCI; IF=3.006; Psychology: 18/77 = 23.4%)
  • Wang HM, Wu MH, Chang PH, Lin HC, Liao CD, Wu SM, Hung TM, Lin CY, Chang TC, Tzu-Tsen Y, Hsieh JCH*. The change in circulating tumor cells before and during concurrent chemoradiotherapy is associated with survival in patients with locally advanced head and neck cancer. Head and Neck 2019; 41(8): 2676-2687. (SCI; IF=2.538; Otorhinolaryngology: 9/42 = 21.4%)
  • Chen SC*, Huang BS, Hung TM, Lin CY , Chang YL. Impact of physical and psychosocial dysfunction on return to work in survivors of oral cavity cancer. Psycho-Oncology 2019; 28(9): 1910-1917. (SCI; IF=3.006; Psychology: 18/77 = 23.4%)
  • CH Lee, JC Hsieh, TM Wu, TS Yeh, HM Wang, YC Lin, JS Chen, CL Lee, WK Huang, TM Hung, TT Yen, SC Chan, WC Chou, FC Kuan, CC Hu, PH Chang*. Baseline circulating stem-like cells predict survival in patients with metastatic breast Cancer. BMC Cancer 2019; 19: 1167. (SCI; IF=3.150; Oncology: 129/244 = 52.9%)
  • Chen SC*, Huang BS, Hung TM, Lin CY, Chang YL. Impact of a behavior change program and health education on social interactions in survivors of head and neck cancer: Randomized controlled trial. Psycho-Oncology 2019; 28(2): 293-300. (SCI; IF=3.006; Psychology: 18/77 = 23.4%)
  • Liw PX, Wen YW, Tsai CY, Chang HK, Tseng CK, Hung TM, Chao YK*. Pretreatment clinical stage predicts locoregional recurrence in patients with esophageal cancer who achieved a complete clinical response to chemoradiotherapy. Journal of Thoracic and Cardiovascular Surgery 2018; 155: 2233-2242. (SCI; IF=4.451; Surgery: 17/210 = 8.1%)
  • Chen SC*, Huang BS, Hung TM, Chang YL, Lin CY, Chung CY, Wu SC. Swallowing ability and its impact on dysphagia-specific health-related QOL in oral cavity cancer patients post-treatment. European Journal of Oncology Nursing 2018; 36: 89-94. (SCI; IF=1.876; Nursing: 30/123 = 24.4%)
  • Wu YY, Chang JT, Lin CY, Fan KH, Huang BS, Hung TM, Hsieh CE, Tsang NM*. Pretreatment lymphocyte count as prognostic factor in patients with head-and-neck cancer. Therapeut Radiol Oncol 2018 Mar; 25: 1-12.
  • Huang SH, Chen YC, Leung WM, Tsai CS, Fan KH, Hung TM, Yap WK, Huang BS*. Treatment outcome in patients with locally advanced gastric cancer receiving adjuvant chemoradiotherapy. Therapeut Radiol Oncol 2017 Mar; 24(1): 1-11.
  • Holliday EB, Garden AS, Rosenthal DI, Fuller CD, Morrison WH, Gunn GB, Phan J, Beadle BM, Zhu XR, Zhang X, Hanna E, Glisson BS, Hutcheson KA, El-Naggar AK, Hong JH, Hung TM, Uzel EK, Lewis G, Frank SJ*. Proton Therapy Reduces Treatment-Related Toxicities for Patients with Nasopharyngeal Cancer: A Case-Match Control Study of Intensity-Modulated Proton Therapy and Intensity-Modulated Photon Therapy. International Journal of Particle Therapy 2015 Jul; 2(1):19–28.
Presentations:(First author only)
  • The Prognostic Implications for 18F-FDG PET Standardized Uptake Value of Primary Tumor and Neck Lymph Nodes in Patients with Nasopharyngeal Carcinoma. The 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO). San Diego, USA. November 3, 2010. Oral presentation.
  • The Prognostic Implications for 18F‐FDG PET Standardized Uptake Value of Primary Tumor and Neck Lymph Nodes in Patients with Nasopharyngeal Carcinoma. 第十六屆台灣癌症聯合學術年會 2011 The 16th Taiwan Joint Cancer Conference. Taipei, Taiwan. May 1, 2011. Oral presentation.
  • Pretreatment 18F-Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Value of Primary Tumor and Neck Lymph Nodes as a Predictor of Distant Metastasis for Patients with Nasopharyngeal Carcinoma. 2012海峽兩岸鼻咽癌高峰論壇 中國大陸福州 Sep. 1, 2012. Oral presentation.
  • Disease Failure Pattern and Survival Outcome between Different Elective Neck Radiation Doses in NPC Patients Treated with IMRT. 第18屆台灣癌症聯合學術年會暨2013海峽兩岸放射腫瘤高峰論壇 2013 The 18th Taiwan Joint Cancer Conference. Taipei, Taiwan. July 13th, 2013. Oral presentation.
  • The Dose of Elective Neck Irradiation as 46 Gy Is Feasible in Nasopharyngeal Carcinoma Treated by Intensity Modulated Radiation Therapy. The 56th Annual Meeting of the American Society for Radiation Oncology (ASTRO). San Francisco, USA. September 14-16, 2014. Poster presentation.
  • Body Image in Irradiated Head and Neck Cancer Patients: the Impact of Surgical Procedures. 2015 World Congress of Psycho-Oncology: a joint conference of APOS (American Psychosocial Oncology Society) and IPOS (International Psycho-Oncology Society). Washington D.C., USA. July 30th, 2015. Oral presentation.